Cryo-Cell International, Inc.
CCEL
$7.17
$0.14262.03%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.99M | 31.84M | 31.64M | 31.37M | 31.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.99M | 31.84M | 31.64M | 31.37M | 31.34M |
| Cost of Revenue | 7.95M | 12.07M | 12.10M | 12.22M | 12.13M |
| Gross Profit | 24.04M | 19.77M | 19.54M | 19.15M | 19.22M |
| SG&A Expenses | 18.52M | 17.96M | 17.61M | 17.63M | 17.17M |
| Depreciation & Amortization | 483.60K | 568.60K | 655.30K | 876.60K | 1.12M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.20M | 31.98M | 31.90M | 32.32M | 31.59M |
| Operating Income | 3.79M | -139.50K | -258.40K | -949.40K | -246.90K |
| Income Before Tax | 2.80M | -12.35M | -12.66M | -13.78M | -13.36M |
| Income Tax Expenses | 2.40M | -3.42M | -3.36M | -4.05M | -3.84M |
| Earnings from Continuing Operations | 0.40 | -8.93 | -9.30 | -9.73 | -9.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 402.10K | -8.93M | -9.30M | -9.73M | -9.52M |
| EBIT | 3.79M | -139.50K | -258.40K | -949.40K | -246.90K |
| EBITDA | 4.48M | 641.30K | 614.70K | 166.40K | 1.15M |
| EPS Basic | 0.05 | -1.07 | -1.12 | -1.17 | -1.15 |
| Normalized Basic EPS | 0.16 | -0.07 | -0.05 | -0.14 | -0.10 |
| EPS Diluted | 0.05 | -1.07 | -1.12 | -1.18 | -1.15 |
| Normalized Diluted EPS | 0.15 | -0.07 | -0.05 | -0.14 | -0.10 |
| Average Basic Shares Outstanding | 32.52M | 32.74M | 32.97M | 33.18M | 33.37M |
| Average Diluted Shares Outstanding | 32.80M | 33.02M | 33.19M | 33.29M | 33.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 502.49% | -- | -- | -- | -- |
